scholarly journals An Overview of the Immunological Defenses in Fish Skin

2012 ◽  
Vol 2012 ◽  
pp. 1-29 ◽  
Author(s):  
María Ángeles Esteban
Keyword(s):  
Immune System ◽  
Lymphoid Tissue ◽  
Health Management ◽  
Current Knowledge ◽  
The Body ◽  
Mucosal Immune System ◽  
Evolutionary Development ◽  
Anatomical Location ◽  
Management Tools ◽  
Vertebrate Immune System

The vertebrate immune system is comprised of numerous distinct and interdependent components. Every component has its own inherent protective value, and the final combination of them is likely to be related to an animal’s immunological history and evolutionary development. Vertebrate immune system consists of both systemic and mucosal immune compartments, but it is the mucosal immune system which protects the body from the first encounter of pathogens. According to anatomical location, the mucosa-associated lymphoid tissue, in teleost fish is subdivided into gut-, skin-, and gill-associated lymphoid tissue and most available studies focus on gut. The purpose of this paper is to summarise the current knowledge of the immunological defences present in skin mucosa as a very important part of the fish immune system, serving as an anatomical and physiological barrier against external hazards. Interest in defence mechanism of fish arises from a need to develop health management tools to support a growing finfish aquaculture industry, while at the same time addressing questions concerning origins and evolution of immunity in vertebrates. Increased knowledge of fish mucosal immune system will facilitate the development of novel vaccination strategies in fish.

scholarly journals Targeting the Gut Mucosal Immune System Using Nanomaterials

Pharmaceutics ◽  
2021 ◽  
Vol 13 (11) ◽  
pp. 1755
Author(s):  
Jacob McCright ◽  
Ann Ramirez ◽  
Mayowa Amosu ◽  
Arnav Sinha ◽  
Amanda Bogseth ◽  
...  
Keyword(s):  
Immune System ◽  
The Body ◽  
Mucosal Immune System ◽  
Lymphoid Tissues ◽  
Gi Tract ◽  
Public Health Burden ◽  
Intestinal Infections ◽  
Significant Public Health ◽  
Inflammatory Processes ◽  
Gi Inflammation

The gastrointestinal (GI) tract is one the biggest mucosal surface in the body and one of the primary targets for the delivery of therapeutics, including immunotherapies. GI diseases, including, e.g., inflammatory bowel disease and intestinal infections such as cholera, pose a significant public health burden and are on the rise. Many of these diseases involve inflammatory processes that can be targeted by immune modulatory therapeutics. However, nonspecific targeting of inflammation systemically can lead to significant side effects. This can be avoided by locally targeting therapeutics to the GI tract and its mucosal immune system. In this review, we discuss nanomaterial-based strategies targeting the GI mucosal immune system, including gut-associated lymphoid tissues, tissue resident immune cells, as well as GI lymph nodes, to modulate GI inflammation and disease outcomes, as well as take advantage of some of the primary mechanisms of GI immunity such as oral tolerance.

scholarly journals Antibiotics and baby’s bugs — what effects have antibiotics on the bacteria present in the infant gut?

2012 ◽  
pp. 19-25
Author(s):  
Fiona Fouhy
Keyword(s):  
Immune System ◽  
Lymphoid Tissue ◽  
Gut Bacteria ◽  
Human Cells ◽  
The Body ◽  
Daily Functioning ◽  
Bacterial Cells ◽  
Beneficial Bacteria ◽  
Human Gut ◽  
Different Types

Take a moment to consider that there are ten times more bacteria present in the human gut than there are human cells in the body. Surprising and shocking as this may be, it should also occur to you that such vast numbers of bacteria are not there just by chance. In fact, these populations play numerous vital roles in our health and daily functioning. There are at least 100 trillion bacterial cells in the human gut, comprising over 500 different types, and these bacteria are involved in diverse and vital roles such as the digestion of foods, including foods which we would otherwise be unable to metabolise due to a lack of appropriate enzymes. These gut bacteria also contribute to the development of the gut-associated lymphoid tissue (GALT; part of the immune system located in the gut which is vital for developing tolerance to beneficial bacteria). Additionally, these gut bacteria ...

scholarly journals The immune system as a biomonitor: explorations in innate and adaptive immunity

2013 ◽  
Vol 3 (2) ◽  
pp. 20120099 ◽  
Author(s):  
Niclas Thomas ◽  
James Heather ◽  
Gabriel Pollara ◽  
Nandi Simpson ◽  
Theres Matjeka ◽  
...  
Keyword(s):  
Immune System ◽  
Immune Responses ◽  
Lymphoid Tissue ◽  
Tissue Injury ◽  
Great Sensitivity ◽  
The Body ◽  
Human Immune System ◽  
Ligand Interactions ◽  
Human Immune ◽  
Body Self

The human immune system has a highly complex, multi-layered structure which has evolved to detect and respond to changes in the internal microenvironment of the body. Recognition occurs at the molecular or submolecular scale, via classical reversible receptor–ligand interactions, and can lead to a response with great sensitivity and speed. Remarkably, recognition is coupled to memory, such that responses are modulated by events which occurred years or even decades before. Although the immune system in general responds differently and more vigorously to stimuli entering the body from the outside (e.g. infections), this is an emergent property of the system: many of the recognition molecules themselves have no inherent bias towards external stimuli (non-self) but also bind targets found within the body (self). It is quite clear that the immune response registers pathophysiological changes in general. Cancer, wounding and chronic tissue injury are some obvious examples. Against this background, the immune system ‘state’ tracks the internal processes of the body, and is likely to encode information regarding both current and past disease processes. Moreover, the distributed nature of most immune responses (e.g. typically involving lymphoid tissue, non-lymphoid tissue, bone marrow, blood, extracellular interstitial spaces, etc.) means that many of the changes associated with immune responses are manifested systemically, and specifically can be detected in blood. This provides a very convenient route to sampling immune cells. We consider two different and complementary ways of querying the human immune ‘state’ using high-dimensional genomic screening methodologies, and discuss the potentials of these approaches and some of the technological and computational challenges to be overcome.

Interactions between gut-associated lymphoid tissue and colonization levels of indigenous, segmented, filamentous bacteria in the small intestine of mice

1998 ◽  
Vol 44 (12) ◽  
pp. 1177-1182 ◽  
Author(s):  
J Snel ◽  
C C Hermsen ◽  
H J Smits ◽  
N A Bos ◽  
WMC Eling ◽  
...  
Keyword(s):  
Small Intestine ◽  
Immune System ◽  
Lymphoid Tissue ◽  
Immune Reaction ◽  
Mucosal Immune System ◽  
Filamentous Bacteria ◽  
Segmented Filamentous Bacteria ◽  
Swiss Mice ◽  
Age Dependent ◽  
Old Mice

Unlike most other indigenous bacteria, segmented filamentous bacteria (SFB) are potent activators of the mucosal immune system. SFB are strongly anchored to the epithelial cells of the small intestine where they have a preference for mucosal lymphoid epithelium. Since SFB are only present in high numbers shortly after weaning, it was investigated whether an SFB-induced immune reaction results in the removal of these bacteria from the small intestine. A correlation was found between age and colonization levels in the small intestines of SFB monoassociated Swiss mice. Five-week-old athymic BALB/c (nu/nu) mice showed lower colonization levels than their heterozygous littermates, but the opposite was found at the age of 12 weeks. However, SFB inoculation of germfree Swiss mice resulted in higher colonization levels in 5-week-old mice when compared with 4-month-old mice. We conclude that SFB colonization levels in the small intestine are likely influenced by the activity of the mucosal immune system. However, an additional age-dependent factor that modulates SFB colonization levels cannot be excluded.Key words: segmented filamentous bacteria, small intestine, gut-associated lymphoid tissue.

scholarly journals Overview of SARS-CoV-2 Infection and Its Potential Reactions

2021 ◽  
Vol 1 (2) ◽  
Author(s):  
Esmaeil Mortaz ◽  
Neda K. Dezfuli
Keyword(s):  
Immune System ◽  
Current Knowledge ◽  
Serum Levels ◽  
The Body ◽  
Immune System Dysfunction ◽  
Pubmed Database ◽  
Tnf Α ◽  
Key Points ◽  
Severity Of The Disease ◽  
Review Current

Context: The immunopathology of SARS-CoV-2 infection in COVID-19 is not well described yet, especially regarding dysregulation of the immune system. In this mini-review, current knowledge about the SARS-CoV-2 infection and immunopathogenesis of COVID-19 disease is described. We also discuss possible induced reactions against SARS-COV-2. Evidence Acquisition: Based on the authors' experience and knowledge, the current review aimed to, firstly, discuss and overview SRAS-CoV-2 infection and reactions in the body, and, secondly, to obtain related subjects from the PubMed database. Results and Conclusion: In most COVID-19 patients, uncontrollable cytokines secretion and mediators are major key points in the pathogenesis of the disease. Of all cytokines and mediators, serum levels of IL-6, IL-1β, TNF-α, IL-8, and soluble TNF-α receptor (sTNFR) have been reported. Lymphopenia and hypoxia, as well as the severity of the disease, can be considered as COVID-19 manifestations. High levels of intracellular NO inside of the red blood cells (RBCs) of patients drive the unexpected silent hypoxia phenotype induced ARDS importantly related to the patient's immune system dysfunction.

scholarly journals Content and location of lymphocyte subpopulations with markers CD4+, CD8+ and CD20+ in the esophageal tonsil of chickens and the Meckel diverticulum of ducks

2021 ◽  
Vol 12 (3) ◽  
pp. 396-402
Author(s):  
V. Т. Khomich ◽  
N. V. Dyshliuk ◽  
T. A. Mazurkevych ◽  
S. V. Guralskа ◽  
S. І. Usenko
Keyword(s):  
Immune System ◽  
Lymphoid Tissue ◽  
Meckel’S Diverticulum ◽  
Lymphocyte Subpopulations ◽  
The Body ◽  
Meckel's Diverticulum ◽  
Meckel Diverticulum ◽  
Statistical Research ◽  
Educational Work ◽  
Lymphoid Nodules

Immune formations of birds' digestive organs, including the esophageal tonsil and Meckel’s diverticulum, protect the body from foreign antigens that enter the body with food and water and play an important role in maintaining the genetic constancy of its internal environment. This unique property of the immune system is formed during ontogenesis and is associated with maintaining the selection of lymphocyte clones that are able to respond to foreign antigens and carry out a specific immune response of two types: humoral and cellular. This article presents the results of a study of T- and B-lymphocyte subpopulations of the esophageal tonsil of Shever 579 cross chickens at the age of 25, 180 and 300 days, the Meckel diverticulum of the Blagovarsky cross ducks at the age of 30, 150 and 180 days. Immunohistochemical and statistical research methods were used to determine the localization and quantitative parameters of cell populations of lymphocytes (CD4+, CD8+, CD20+) using monoclonal antibodies and the DAKO EnVision FLEX+ imaging system (Dako Cytomation, Denmark). Separate subpopulations of T-lymphocytes (CD4+ - helpers, CD8+ -cytotoxic / T-suppressors) and mature B-lymphocytes (CD20+) were found in the esophageal tonsil and Meckel diverticulum of birds. Their presence confirms that antigen-independent proliferation and differentiation of lymphocytes into effector cells occur in the immune formations of the digestive system. The lymphoid tissue of these formations is represented mainly by a well-defined diffuse form and nodules with light centers (secondary). In the esophageal tonsil of chickens, these structures are located in the tunica mucosa and tela submucosa, and in the Meckel diverticulum of ducks – also in the tunica muscularis. The content of lymphocytes with these markers predominates in diffuse lymphoid tissue compared to that in secondary lymphoid nodules. In the diffuse lymphoid tissue of the esophageal tonsil, lymphocytes are located mainly near the adenomeres and excretory ducts of the esophageal glands, blood vessels, and under the surface epithelium, and in Meckel’s diverticulum – around the crypts, in their epithelium and in the epithelium of the villi. They are also found in the light centers of lymphoid nodules and on their periphery. The indices of the content of lymphocytes with the indicated markers in the esophageal tonsil and Meckel diverticulum which we determined were associated with age characteristics of the poultry in the postnatal period of ontogenesis. According to our observations, the content of CD20+ lymphocytes was the highest, while the populations of CD4+ and CD8+ lymphocytes were much smaller. This indicates an increase in the activity and predominance of the humoral immunity over the cellular one. The content of CD20+ lymphocytes was highest in birds at the age of 180 days, that is, during their sexual maturity. The data presented in the work can be used by morphologists researching the organs of the immune system, immunologists, poultry specialists involved in breeding, using and raising poultry and in educational work.

scholarly journals Mucosal Vaccination via the Respiratory Tract

Pharmaceutics ◽  
2019 ◽  
Vol 11 (8) ◽  
pp. 375 ◽  
Author(s):  
Hellfritzsch ◽  
Scherließ
Keyword(s):  
Immune Response ◽  
Immune System ◽  
Respiratory Tract ◽  
Human Body ◽  
Cellular Immune Response ◽  
The Body ◽  
Mucosal Immune System ◽  
Cytotoxic T Cell ◽  
Vaccine Administration ◽  
Cellular Immune

Vaccine delivery via mucosal surfaces is an interesting alternative to parenteral vaccine administration, as it avoids the use of a needle and syringe. Mucosal vaccine administration also targets the mucosal immune system, which is the largest lymphoid tissue in the human body. The mucosal immune response involves systemic, antigen-specific humoral and cellular immune response in addition to a local response which is characterised by a predominantly cytotoxic T cell response in combination with secreted IgA. This antibody facilitates pathogen recognition and deletion prior to entrance into the body. Hence, administration via the respiratory mucosa can be favoured for all pathogens which use the respiratory tract as entry to the body, such as influenza and for all diseases directly affecting the respiratory tract such as pneumonia. Additionally, the different mucosal tissues of the human body are interconnected via the so-called “common mucosal immune system”, which allows induction of an antigen-specific immune response in distant mucosal sites. Finally, mucosal administration is also interesting in the area of therapeutic vaccination, in which a predominant cellular immune response is required, as this can efficiently be induced by this route of delivery. The review gives an introduction to respiratory vaccination, formulation approaches and application strategies.

scholarly journals Review of Dendritic Cells, Their Role in Clinical Immunology, and Distribution in Various Animal Species

2021 ◽  
Vol 22 (15) ◽  
pp. 8044
Author(s):  
Mohammed Yusuf Zanna ◽  
Abd Rahaman Yasmin ◽  
Abdul Rahman Omar ◽  
Siti Suri Arshad ◽  
Abdul Razak Mariatulqabtiah ◽  
...  
Keyword(s):  
Immune Response ◽  
Dendritic Cells ◽  
Immune System ◽  
Clinical Immunology ◽  
Viral Infections ◽  
Current Knowledge ◽  
The Body ◽  
Primary Immune Response ◽  
Hematopoietic Stem ◽  
General Aspects

Dendritic cells (DCs) are cells derived from the hematopoietic stem cells (HSCs) of the bone marrow and form a widely distributed cellular system throughout the body. They are the most efficient, potent, and professional antigen-presenting cells (APCs) of the immune system, inducing and dispersing a primary immune response by the activation of naïve T-cells, and playing an important role in the induction and maintenance of immune tolerance under homeostatic conditions. Thus, this review has elucidated the general aspects of DCs as well as the current dynamic perspectives and distribution of DCs in humans and in various species of animals that includes mouse, rat, birds, dog, cat, horse, cattle, sheep, pig, and non-human primates. Besides the role that DCs play in immune response, they also play a pathogenic role in many diseases, thus becoming a target in disease prevention and treatment. In addition, its roles in clinical immunology have also been addressed, which include its involvement in transplantation, autoimmune disease, viral infections, cancer, and as a vaccine target. Therefore, based on the current knowledge and understanding of the important roles they play, DCs can be used in the future as a powerful tool for manipulating the immune system.

Sign in / Sign up

Export Citation Format

Share Document